PMS-REPAGLINIDE 0.5, 1, 2 mg (2017-04-18)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 1503616 | B. 1 mg Repaglinide | - Recalling Firm
- Pharmascience Inc.
- 100, 6111 Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
- Marketing Authorization Holder
- Pharmascience Inc.
- 100, 6111 Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
| Tablet | DIN 02354934 | 1 mg Repaglinide |
| 1503758 | 2 mg Repaglinide | - Recalling Firm
- Pharmascience Inc.
- 100, 6111 Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
- Marketing Authorization Holder
- Pharmascience Inc.
- 100, 6111 Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
| Tablet | DIN 02354942 | 2 mg Repaglinide |
| 1505633 | pms-REPAGLINIDE 0.5 mg | - Recalling Firm
- Pharmascience Inc.
- 100, 6111 Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
- Marketing Authorization Holder
- Pharmascience Inc.
- 100, 6111 Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
| Tablet | DIN 02354926 | 0.5 mg Repaglinide |
Affected products
-
pms-REPAGLINIDE 0.5 mg
-
pms-REPAGLINIDE 1 mg
-
pms-REPAGLINIDE 2 mg
Out of specification for degradation product during stability program